Walleye Trading’s ESSA Pharma EPIX Stock Holding History

Walleye Trading’s Portfolio EPIX Stock Details EPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-27,660	Closed	-$221K	–	5475
2021 Q3	$221K	Buy	+27,660	New	+$440K	﹤0.01%	3757

Other funds holding EPIX

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Walleye Trading's EPIX Position: Q4 2021 in Review

Walleye Trading sold out of ESSA Pharma (EPIX) in Q4 2021, closing a stake of 27,660 shares — an estimated $221K sold.

Walleye Trading first reported a position in EPIX in Q3 2021 and held it in 1 quarter. The position peaked at $221K in Q3 2021. 60 funds tracked by Wall St. Rank hold EPIX as of Q4 2021.

Walleye Trading reported no remaining ESSA Pharma position as of Q4 2021 after selling out during the quarter.
Walleye Trading sold 27,660 ESSA Pharma shares in Q4 2021, an estimated $221K.
Walleye Trading first reported a position in ESSA Pharma in Q3 2021 and held it in 1 quarter.
Walleye Trading's ESSA Pharma position peaked at $221K in Q3 2021.
60 funds tracked by Wall St. Rank held ESSA Pharma as of Q4 2021.

Based on Walleye Trading's 13F filing for Q4 2021, filed 14 Feb 2022.